NO149210C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-(1-pyrazolyl)-pyridazinderivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-(1-pyrazolyl)-pyridazinderivater

Info

Publication number
NO149210C
NO149210C NO782043A NO782043A NO149210C NO 149210 C NO149210 C NO 149210C NO 782043 A NO782043 A NO 782043A NO 782043 A NO782043 A NO 782043A NO 149210 C NO149210 C NO 149210C
Authority
NO
Norway
Prior art keywords
pyrazolyl
preparation
therapeutic active
pyridazine derivatives
analogy procedure
Prior art date
Application number
NO782043A
Other languages
English (en)
Norwegian (no)
Other versions
NO149210B (no
NO782043L (no
Inventor
Geza Szilagyi
Endre Kasztreiner
Laszlo Tardos
Edit Kosa
Laszlo Jaszlits
Gyoergy Cseh
Andras Divald
Pal Tolnay
Sandor Elek
Istvan Elekes
Istvan Polgari
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO782043L publication Critical patent/NO782043L/no
Publication of NO149210B publication Critical patent/NO149210B/no
Publication of NO149210C publication Critical patent/NO149210C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO782043A 1977-06-13 1978-06-12 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-(1-pyrazolyl)-pyridazinderivater NO149210C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77GO1373A HU175471B (hu) 1977-06-13 1977-06-13 Sposob poluchenija novykh proizvodnykh 3-skobka-1-pirazolil-skobka zakryta-piridazina

Publications (3)

Publication Number Publication Date
NO782043L NO782043L (no) 1978-12-14
NO149210B NO149210B (no) 1983-11-28
NO149210C true NO149210C (no) 1984-03-07

Family

ID=10996834

Family Applications (1)

Application Number Title Priority Date Filing Date
NO782043A NO149210C (no) 1977-06-13 1978-06-12 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-(1-pyrazolyl)-pyridazinderivater

Country Status (25)

Country Link
US (1) US4251658A (de)
JP (1) JPS5416487A (de)
AT (1) AT357548B (de)
AU (1) AU521394B2 (de)
BE (1) BE867967A (de)
BG (1) BG28709A3 (de)
CA (1) CA1095912A (de)
CH (1) CH638202A5 (de)
CS (1) CS204029B2 (de)
DD (1) DD140043A5 (de)
DE (1) DE2825906A1 (de)
DK (1) DK263078A (de)
ES (1) ES470750A1 (de)
FI (1) FI64156C (de)
FR (1) FR2394542A1 (de)
GB (1) GB1603958A (de)
HU (1) HU175471B (de)
IL (1) IL54816A (de)
IT (1) IT1098216B (de)
NL (1) NL7806380A (de)
NO (1) NO149210C (de)
PL (1) PL111252B1 (de)
SE (1) SE437517B (de)
SU (2) SU797577A3 (de)
YU (1) YU140078A (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU176100B (en) * 1977-10-25 1980-12-28 Gyogyszerkutato Intezet Process for preparing new 3-/1-pyrazolyl/-pyridazine derivatives
DE2935359A1 (de) * 1979-09-01 1981-03-26 Basf Ag, 67063 Ludwigshafen 6-imidazolyl-3-hydrazino-pyridazine
DE3130251A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(4-((omega)-(1-imidazolyl)-alkyl)-phenyl)-3-oxo -2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4353905A (en) * 1981-09-17 1982-10-12 Warner-Lambert Company Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones
US4590194A (en) * 1981-10-05 1986-05-20 Sterling Drug Inc. 3-[methyl or dimethyl)amino]-6-(pyridinyl)pyridazines and their cardiotonic use
US4503056A (en) * 1982-03-02 1985-03-05 Abbott Laboratories 1-(Pyridazinyl)pyrazoline derivatives
DE3825867A1 (de) * 1988-03-04 1989-09-14 Bayer Ag Heterocyclisch substituierte sulfonylaminoazole und ihre verwendung als herbizide
US5536701A (en) * 1994-10-11 1996-07-16 Monsanto Company 3-pyrazolyloxypyridazines, herbicidal compositions and uses thereof
FR2847160A1 (fr) * 2002-11-20 2004-05-21 Oreal Composition capillaire contenant un compose pyrasol-carboxamide, son utilisation pour stimuler la pousse des cheveux et/ou freiner leur chute
EP1565150A1 (de) * 2002-11-20 2005-08-24 L'oreal Verwendung eines pyrazolcarboxamidderivates zur stimulation von keratinischem faserwachstum und/oder zur verhinderung von dessen verlust
EP2233470B1 (de) * 2005-07-04 2011-12-07 High Point Pharmaceuticals, LLC Histamine H3 Receptor Antagonisten
RU2442775C2 (ru) * 2005-07-04 2012-02-20 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
JP2009537596A (ja) * 2006-05-23 2009-10-29 ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー 6−(4−シクロプロピルピペリジン−1−イル)−2’−メチル−[3,4’]−ビピリジン及びその医薬としての使用
SG163547A1 (en) * 2006-05-29 2010-08-30 High Point Pharmaceuticals Llc 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
EP2014656A3 (de) * 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC Neue heterocyclische H3-Antagonisten
WO2011133920A1 (en) 2010-04-23 2011-10-27 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) * 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1595920B2 (de) * 1964-11-04 1978-08-10 Merck Patent Gmbh, 6100 Darmstadt 4-(co-Piperazinoalkyl)-pyrazole, ihre Salze und Verfahren zu ihrer Herstellung
JPS5831347B2 (ja) * 1975-09-05 1983-07-05 中外製薬株式会社 ピラゾリルピリダジンユウドウタイノ セイホウ

Also Published As

Publication number Publication date
AU521394B2 (en) 1982-04-01
SE437517B (sv) 1985-03-04
IL54816A (en) 1981-09-13
BE867967A (fr) 1978-12-11
BG28709A3 (en) 1980-06-16
AU3683678A (en) 1979-12-06
FI781856A (fi) 1978-12-14
NO149210B (no) 1983-11-28
DE2825906A1 (de) 1979-01-18
IT7824490A0 (it) 1978-06-13
CS204029B2 (en) 1981-03-31
GB1603958A (en) 1981-12-02
NL7806380A (nl) 1978-12-15
ATA414478A (de) 1979-12-15
SE7806576L (sv) 1978-12-14
ES470750A1 (es) 1979-01-16
CA1095912A (en) 1981-02-17
PL207570A1 (pl) 1979-05-21
US4251658A (en) 1981-02-17
IT1098216B (it) 1985-09-07
JPS5416487A (en) 1979-02-07
DK263078A (da) 1978-12-14
JPS569506B2 (de) 1981-03-02
DD140043A5 (de) 1980-02-06
FI64156B (fi) 1983-06-30
SU797577A3 (ru) 1981-01-15
FR2394542A1 (fr) 1979-01-12
FI64156C (fi) 1983-10-10
IL54816A0 (en) 1978-07-31
FR2394542B1 (de) 1980-12-05
SU860703A1 (ru) 1981-08-30
AT357548B (de) 1980-07-10
YU140078A (en) 1983-01-21
NO782043L (no) 1978-12-14
HU175471B (hu) 1980-08-28
PL111252B1 (en) 1980-08-30
CH638202A5 (de) 1983-09-15

Similar Documents

Publication Publication Date Title
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO147148C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater
NO152217C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 3-(1-imidazolylalkyl)indoler
NO800858L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater
NO157817C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycinamidderivater.
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO151085C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater
NO153135C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-(fenoksyalkyl)-imidazolderivater.
NO149210C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-(1-pyrazolyl)-pyridazinderivater
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO149312C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(2-tenoyltio)-propionylglycin
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO149737C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azaxanthon-3-carboxylsyrer
NO149354C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-(1-pyrazolyl)-pyridazinderivater
NO150158C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater
NO149964C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-(tetrazol-5-yl)-1-azaxanthoner
NO149960C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive bis(nitrosoureido)-polyolderivater
NO152172C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO155054C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-amino-1-benzoxepin-5(2h)-derivater.
NO147749C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive n-acryl-2-hydroxy-1,3-diaminopropaner
NO146744C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme (omega-aminoalkoksy)-dibenzyl derivater
NO153726C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-(nafthalenyloxy)-piperidinderivater.